You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

herceptin®

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Beijing (QL1701, Herceptin®, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences
Nov 18, 2022

Breast Cancer, Breast Tumors, HER2-positive Breast Cancer Trial in Worldwide (TX05 (trastuzumab), Herceptin®, Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • +4 more
  • TX05 (trastuzumab)
  • +4 more
  • Lesnoy, Minsk Region, Belarus
  • +145 more
Jan 7, 2022

HER2-positive Metastatic Breast Cancer Trial in Harbin, Shanghai (TQ-B211, Herceptin®, docetaxel)

Unknown status
  • HER2-positive Metastatic Breast Cancer
  • Harbin, Heilongjiang, China
  • +1 more
May 9, 2020

Breast Cancer Trial in United States (Albumin-bound paclitaxel, Carboplatin, Herceptin®)

Completed
Has Results
  • Breast Cancer
  • Albumin-bound paclitaxel
  • +2 more
  • Long Beach, California
  • +13 more
Nov 13, 2019

Metastatic Breast Cancer Trial in Worldwide (PF-05280014, Paclitaxel, Herceptin®)

Completed
Has Results
  • Metastatic Breast Cancer
  • PF-05280014
  • +2 more
  • Plainville, Connecticut
  • +187 more
Jun 7, 2021

Carcinoma, Metastatic Breast Trial in United States (CPG 7909, Herceptin®)

Completed
  • Carcinoma, Metastatic Breast
  • CPG 7909
  • Herceptin®
  • Farmington, Connecticut
  • +7 more
May 26, 2011

Carcinoma, Breast Trial in United States (0.04 mg/kg CpG 7909, Herceptin®, 0.08 mg/kg CpG 7909)

Completed
  • Carcinoma, Breast
  • 0.04 mg/kg CpG 7909
  • +4 more
  • Berkely, California
  • +11 more
Mar 11, 2009